Article du Bulletin
Treatment of chronic viral hepatitis [Traitement de l’hépatite virale chronique].
Main J., McCarron B. & Thomas H.C. · 1998 · Antivir. Chem. Chemother., 9(6): 449-60.
Votre navigateur n’affiche pas l’aperçu PDF. Ouvrir le PDF →
Résumé
Interferon-alpha therapy has proved effective for up to 40% of patients with adult-acquired chronic hepatitis B virus (HBV) infection and for 20-25% of those with chronic hepatitis C virus (HCV) infection. Nucleoside analogues, such as lamivudine and famciclovir, are showing promise as antiviral agents for chronic HBV and the combination of interferon-alpha and ribavirin is proving to be successful therapy for 40-50% of patients with chronic HCV. In this article we review current therapy and discuss future strategies of the therapy of chronic viral hepatitis.